In Stock Rabbit Anti Human Akr1b1 Polyclonal Affinity Purified (pbs With 0.05% Sodium Azide And 50% Glycerol, Ph7.4) (western Blot,ihc,elisa) Bundle [71PYGloN]

Rabbit Anti Human AKR1B1 Polyclonal Antibody

Discover the innovative Rabbit Anti Human AKR1B1 Polyclonal Antibody, a powerful tool for your research needs. This high-quality antibody is designed to detect and quantify the human AKR1B1 protein, offering exceptional specificity and sensitivity. Engineered for versatility, this antibody is optimized for use in various applications, including Western Blot, Immunohistochemistry (IHC), and Enzyme-Linked Immunosorbent Assay (ELISA). Its liquid format and convenient storage conditions make it an ideal choice for researchers seeking reliable and consistent results.

Product Specifications and Features

This antibody is affinity-purified to ensure maximum purity and consistency. Hosted in rabbit, it is raised against a synthetic peptide of human AKR1B1, providing a robust target-specific response. The antibody is buffered in PBS with 0.05% sodium azide and 50% glycerol, pH 7.4, ensuring optimal stability and compatibility with various experimental conditions. Key features include:

Host Species: Rabbit

Species Reactivity: Human

Target: AKR1B1

Clonality: Polyclonal

Purity: Affinity Purified

Immunogen: Synthetic peptide of human AKR1B1

With these specifications, the Rabbit Anti Human AKR1B1 Polyclonal Antibody is a reliable and versatile tool for your research studies.

Applications and Benefits

The Rabbit Anti Human AKR1B1 Polyclonal Antibody is an invaluable asset for researchers investigating the role of AKR1B1 in various biological processes. Its applications include:

Western Blot: Detect and quantify AKR1B1 expression in cell lysates and tissue samples.

Immunohistochemistry (IHC): Visualize AKR1B1 protein expression in formalin-fixed, paraffin-embedded tissues.

ELISA: Measure AKR1B1 protein levels in biological fluids.

This antibody is a critical component for studies related to diabetic complications, as AKR1B1 plays a pivotal role in the reduction of glucose to sorbitol, contributing to the development of these conditions. By choosing this antibody, researchers can expect consistent, reliable results that drive their research forward.